These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35024360)

  • 21. Incidence and outcomes of long QTc in acute medical admissions.
    Mahmud R; Gray A; Nabeebaccus A; Whyte MB
    Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
    Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
    Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
    Koh HM; Chong PF; Tan JN; Chidambaram SK; Chua HJ
    J Clin Pharm Ther; 2021 Jun; 46(3):800-806. PubMed ID: 33768612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.
    Ding J; Liu W; Guan H; Feng Y; Bao Y; Li H; Wang X; Zhou Z; Chen Z
    Medicine (Baltimore); 2021 Jul; 100(28):e26538. PubMed ID: 34260531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.
    Hasnain M; Vieweg WV; Howland RH; Kogut C; Breden Crouse EL; Koneru JN; Hancox JC; Digby GC; Baranchuk A; Deshmukh A; Pandurangi AK
    Ther Adv Psychopharmacol; 2014 Jun; 4(3):130-8. PubMed ID: 25057346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Induced QTc Prolongation: What We Know and Where We Are Going.
    Mangona E; Sandonato E; Brothers TN; Pawasauskas J
    Curr Drug Saf; 2022; 17(2):100-113. PubMed ID: 34551700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
    Ryan K; Benz P; Zosel A; Farkas A; Theobald J
    Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
    Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA
    Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.
    Hancox JC; Hasnain M; Vieweg WV; Crouse EL; Baranchuk A
    Ther Adv Infect Dis; 2013 Oct; 1(5):155-65. PubMed ID: 25165550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain.
    Madden K; Jo E; Williams JL; Liu D; Bruera E
    J Pain Symptom Manage; 2019 Oct; 58(4):678-684. PubMed ID: 31195079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study.
    El Kadri M; Al Falasi O; Ahmed R; Al Awadhi A; Altaha Z; Hillis A; Panikkaveetil B; Abdalla S; Ansel Benette H; Almubarak A; Saifuddin M; Alattar Y; Oulhaj A; AlKaabi S
    BMJ Open; 2022 Feb; 12(2):e051579. PubMed ID: 35140148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long QTc and torsades de pointes in human immunodeficiency virus disease.
    Kocheril AG; Bokhari SA; Batsford WP; Sinusas AJ
    Pacing Clin Electrophysiol; 1997 Nov; 20(11):2810-6. PubMed ID: 9392812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
    Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP
    Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality?
    Madioko Makanzu B; Makulo JR; Ndona Mandina M; Wumba DR; Mashi Longokolo M; Situakibanza H; Odio O; Sonzi Mangala D; Mihigo Bashengezi C; Kabwe Mwilambwe B; Kabanda Kurhenga G; Longo-Mbenza B; Mwimba Mbungu R
    World J Virol; 2024 Jun; 13(2):90668. PubMed ID: 38984083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.
    Tisdale JE; Jaynes HA; Kingery JR; Overholser BR; Mourad NA; Trujillo TN; Kovacs RJ
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):381-90. PubMed ID: 24803473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors of QTc Prolongation in Women With Hormone Receptor‒positive/Human Epidermal Growth Factor Receptor 2‒negative Metastatic Breast Cancer: A Retrospective Analysis of Health Care Claims Data.
    Ward M; Harnett J; Bell TJ; Mardekian J
    Clin Ther; 2019 Mar; 41(3):494-504.e1. PubMed ID: 30792074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
    Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
    BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
    Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative torsade de pointes: a systematic review of published case reports.
    Johnston J; Pal S; Nagele P
    Anesth Analg; 2013 Sep; 117(3):559-564. PubMed ID: 23744954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.